Steve Elms - Jun 6, 2023 Form 4 Insider Report for Marker Therapeutics, Inc. (MRKR)

Role
Director
Signature
/s/ Michael Loiacono, Attorney-in-Fact
Stock symbol
MRKR
Transactions as of
Jun 6, 2023
Transactions value $
$0
Form type
4
Date filed
6/8/2023, 09:32 PM
Previous filing
Mar 8, 2023
Next filing
Feb 28, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRKR Stock Option (right to buy) Award $0 +8K $0.00 8K Jun 6, 2023 Common Stock 8K $1.72 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests on June 6, 2024, subject to the Reporting Person's continued service as a director through the vesting date.